APA

Neumayer H. H., Paradis K., Korn A., Jean C., Fritsche L., Budde K., Winkler M., Kliem V., Pichlmayr R., Hauser I. A., Burkhardt K., Lison A. E., Barndt I. & Appel-Dingemanse S. (20000111). Entry-into-human study with the novel immunosuppressant SDZ RAD in stable renal transplant recipients. : British journal of clinical pharmacology.

Chicago

Neumayer H H, Paradis K, Korn A, Jean C, Fritsche L, Budde K, Winkler M, Kliem V, Pichlmayr R, Hauser I A, Burkhardt K, Lison A E, Barndt I and Appel-Dingemanse S. 20000111. Entry-into-human study with the novel immunosuppressant SDZ RAD in stable renal transplant recipients. : British journal of clinical pharmacology.

Harvard

Neumayer H. H., Paradis K., Korn A., Jean C., Fritsche L., Budde K., Winkler M., Kliem V., Pichlmayr R., Hauser I. A., Burkhardt K., Lison A. E., Barndt I. and Appel-Dingemanse S. (20000111). Entry-into-human study with the novel immunosuppressant SDZ RAD in stable renal transplant recipients. : British journal of clinical pharmacology.

MLA

Neumayer H H, Paradis K, Korn A, Jean C, Fritsche L, Budde K, Winkler M, Kliem V, Pichlmayr R, Hauser I A, Burkhardt K, Lison A E, Barndt I and Appel-Dingemanse S. Entry-into-human study with the novel immunosuppressant SDZ RAD in stable renal transplant recipients. : British journal of clinical pharmacology. 20000111.